LIF and pancreatic ductal adenocarcinoma: LIF is a key paracrine factor from stromal cells acting on cancer cells; and LIF blockade or genetic LIFR deletion slows tumor progression, and augments the efficacy of chemotherapy to prolong survival of pancreatic ductal adenocarcinoma [PDAC] [34].